G. Dultz

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

G. Dultz, Albrecht Piiper, Stefan Zeuzem et al. · Alimentary Pharmacology & Therapeutics · 2014 · 113 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

The Protein Tyrosine Phosphatase Non-Receptor Type 22 C1858T Polymorphism Is a Joint Susceptibility Locus for Immunthyroiditis and Autoimmune Diabetes

G. Dultz, N. Matheis, Manuela Dittmar et al. · Thyroid · 2008 · 91 citations

Life Sciences, Endocrinology, Genetics +17

Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura

G. Dultz, Bernd Kronenberger, Alireza Azizi et al. · Journal of Hepatology · 2011 · 43 citations · Full text

Medicine, Hematology, Pharmacology +14

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus

G. Dultz, Ludmila Gerber, Harald Farnik et al. · Journal of Viral Hepatitis · 2014 · 38 citations

Medicine, Infectious Diseases, Pathology +17

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

Fabian Finkelmeier, G. Dultz, Kai‐Henrik Peiffer et al. · Liver Cancer · 2018 · 38 citations · Full text

Medicine, Infectious Diseases, Oncology +15